A New Conversational AI SaaS Solution for Cancer Clinical Trial Matching

New solution named ‘Tara’ provides embeddable and scalable patient engagement platform for hospitals, health systems and CROs.

Tara Expands Belong’s Proven Clinical Matching Services to Thousands More Patients.

Belong.Life, a leading global provider of high-engagement patient communities and care platforms, today announced the launch of Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions, following the launch of Dave, the world’s first conversational AI oncology mentor.

Continue Reading >

More Articles

Belong.Life Revolutionizing Patient Support

Belong.Life is transforming digital health with AI-driven platforms for patients communities, offering personalized guidance from health…

Eliran Malki Presents His Visionary Approach to AI in Healthcare

No one can dispute that AI in healthcare has consumed most all the air in…

Dave AI – a Revolutionary Tool for Cancer Patients

Promise and Peril of Instant Health Information Access for Consumers. Apps and AI Help Patients…
Skip to content